1AMBRUOSI A,YAMAOTO H,KREUTER J.Body distribution of polysorbate-80 and doxorubicin-loaded[(14) C] poly (butyl cyanoacrylate) nanoparticles after i.v.administration in rats[J].J Drug Target,2005,13(10):535 -542. 被引量：1
2JUNPING W,TAKAYAM K,NAGAI T,et al.Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG-lipid,oleic acid,vitamin E and cholesterol[J].Int J Pharm,2003,251(1 -2):13-21. 被引量：1
3XIONG XB,HUANG Y,LU WL,et al.Enhanced intracellular delivery and improved antitumor efficacy of doxorubicin by sterically stabilized liposomes modified with a synthetic RGD mimetic[J].J Control Release,2005,107 (2):262-275. 被引量：1
4TORCHILIN VP,LEVCHENKO TS,RAMMOHAN R,et al.Cell transfection in vitro and in vivo with nontoxic TAT peptide-liposomeDNA complexes[J].Proc Natl Acad Sci USA,2003,100(4):1972-1977. 被引量：1
5VAAGE J,MAYHEW E,LASIC D,et al.Therapy of primary and metastatic mouse mammary carcinomas with doxorubicin encapsulated in long circulating liposomes[J].Int J Cancer,1992,51(6):942-948. 被引量：1
10WANG JP, TAKAYAMA K, NAGAI T, et al. Pharmacokinetics and antitumor effects of vincristine carried by microemulsions composed of PEG lipid, oleic acid, vitamin E and cholesterol [J]. Int J Pharm, 2003 , 251(1/2):13-16. 被引量：1
